Package 0002-6120-60

{"route": ["ORAL"], "spl_id": "94e137ac-9f6b-4904-8999-3e55603a2407", "openfda": {"nui": ["N0000175605", "N0000193947", "N0000187062", "N0000190114", "N0000185503", "N0000190113", "N0000191423"], "unii": ["CEGM9YBNGD"], "rxcui": ["2370164", "2370170", "2370172", "2370174", "2679805", "2679808", "2679810", "2679812", "2679813", "2679814", "2679815", "2679816"], "spl_set_id": ["7fa848ba-a59c-4144-9f52-64d090f4d828"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Rearranged during Transfection (RET) Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, COATED in 1 BOTTLE (0002-6120-60)", "package_ndc": "0002-6120-60", "marketing_start_date": "20240410"}], "brand_name": "RETEVMO", "product_id": "0002-6120_94e137ac-9f6b-4904-8999-3e55603a2407", "dosage_form": "TABLET, COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Rearranged during Transfection (RET) Inhibitors [MoA]"], "product_ndc": "0002-6120", "generic_name": "selpercatinib", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RETEVMO", "active_ingredients": [{"name": "SELPERCATINIB", "strength": "120 mg/1"}], "application_number": "NDA218160", "marketing_category": "NDA", "marketing_start_date": "20240410", "listing_expiration_date": "20261231"}